Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Catalyst Pharm Inc (NQ: CPRX ) 21.89 +0.09 (+0.41%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Catalyst Pharm Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology February 21, 2024 Santhera's Study Reports the Results of the 48-Week Treatment with Vamorolone in Patients with Duchenne Muscular Dystrophy (DMD) in the VISION-DMD Study, Supporting the Long-Term Efficacy and Safety... From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024 February 14, 2024 The Company will Host a Conference Call and Webcast on February 29, 2024, at 8:30 AM ET From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Why Catalyst Pharmaceuticals Stock Is Trading Lower January 05, 2024 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 13% to $14.89 Friday morning. Via Benzinga Recap: Catalyst Pharmaceuticals Q3 Earnings November 08, 2023 Via Benzinga Jim Cramer Likes This Bank 'Very, Very Much,' Says Stock Is Up 7% Over Past 6 Months January 22, 2024 On CNBC’s "Mad Money Lightning Round," Jim Cramer said Stanley Black & Decker, Inc. Via Benzinga Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances January 18, 2024 With our improving economy, you need to invest in these top biotech stocks that are looking to strike gold this year. Via InvestorPlace Topics Economy Exposures Economy 3 Biotech Stocks You Can Buy and Hold for the Next Decade January 15, 2024 These companies are still in the early innings of their growth potential. Via The Motley Fool Forget Shiba Inu: This Stock is Poised for a Potential Bull Run in 2024 January 14, 2024 With multiple drugs on the market and revenue ramping up, the sky's the limit. Via The Motley Fool Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering January 09, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire 3 Unstoppable S&P 600 Small-Cap Stocks to Buy in January January 08, 2024 Small-cap stocks tend to outperform mid- and large-cap stocks over time and make for an important component of a balanced portfolio. Via InvestorPlace Topics Stocks Exposures US Equities Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 05, 2024 Shares of Applied Therapeutics, Inc. Via Benzinga Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 January 05, 2024 Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain. Via Investor's Business Daily Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock January 05, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session January 05, 2024 U.S. stock futures were lower this morning, with the Dow Jones futures falling around 50 points on Friday. Via Benzinga Topics Stocks Exposures US Equities Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock January 04, 2024 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Amgen Stock Sees Relative Strength Rating Improve To 74 December 29, 2023 Amgen stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 74. Via Investor's Business Daily Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study December 28, 2023 On Thursday, Cytokinetics stock cleared a key performance benchmark, with its Relative Strength Rating jumping to 99 from 89 the day before. Via Investor's Business Daily Ultragenyx Pharm Stock Hits 80-Plus Relative Strength Rating Benchmark December 28, 2023 On Thursday, Ultragenyx Pharm stock received a positive adjustment to its Relative Strength (RS) Rating, from 77 to 81. Via Investor's Business Daily Recursion Pharm Showing Market Leadership As Biotech Stocks Shoot Higher December 26, 2023 On Tuesday, Recursion Pharm stock reached a key technical benchmark, seeing its Relative Strength Rating jump to 91 from 88 the day before. Via Investor's Business Daily Small Caps Are On A Tear Including Speculative Biotechs December 26, 2023 So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation. Via Talk Markets Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 21, 2023 Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings. Via Benzinga Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma December 18, 2023 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire 7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar December 17, 2023 While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside. Via InvestorPlace Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies December 05, 2023 Catalyst Ranked #4 on the List From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions December 04, 2023 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference November 16, 2023 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update November 08, 2023 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire 3 Robinhood Stocks to Buy Right Now November 05, 2023 The no-cost trading platform's customers have their clear favorites, and they're more mainstream names than you might expect them to be. Via The Motley Fool Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE® November 02, 2023 New Patents Further Reinforce the FIRDAPSE® (amifampridine) Intellectual Patent Portfolio From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo October 30, 2023 From Catalyst Pharmaceuticals, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
